MicroPort CardioFlow Medtech Corp (hkse:02160) Share Price

Company Profile

Business description
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
Contact
No. 1601 Zhangdong Road
Zhangjiang Hi-Tech Park
Pudong New District
Shanghai201203
CHN
T: +86 2138954600
https://www.cardioflowmedtech.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
417

Recommended

This ASX share is 84% overvalued and lacks a sustainable competitive advantage.

Shaun Ler | 10 March 2026

A broad assessment of AI’s threats and opportunities leads to moat ratings changes for more than three dozen companies.

Tom Lauricella | 09 March 2026

We’ve also lowered our fair value estimate of Baidu stock.

Chelsey Tam | 09 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,924.20	83.70	0.95%
CAC 40	8,034.34	40.85	0.51%
DAX 40	23,906.88	497.51	2.13%
Dow JONES (US)	47,740.80	239.25	0.50%
FTSE 100	10,399.69	150.17	1.47%
HKSE	25,959.90	202.61	0.79%
NASDAQ	22,695.95	308.27	1.38%
Nikkei 225	54,248.39	1,372.45	-2.47%
NZX 50 Index	13,094.37	523.52	-3.84%
S&P 500	6,795.99	55.97	0.83%
S&P/ASX 200	8,692.60	90.30	1.05%
SSE Composite Index	4,123.14	26.54	0.65%